Skip to main content

Therapies and practice guidelines in internal medicine are constantly evolving as new evidence arises. The busy practicing clinician is limited in time to attend live courses to keep up to date and critically evaluate the medical literature. The aim of this program is to provide the practicing clinician with focused updates on specific topics in internal medicine. Each course will be approximately 20-30 minutes, long enough to cover the topic but short enough to keep the learner actively engaged. *Learners will receive a separate certificate for each course.

What You'll Learn

  • How to apply new practice recommendations in internal medicine to their local practices, customized to local resources
  • The ability to evaluate the latest developments in therapeutic options
  • How to apply new treatments and best practices for disease management

  • Average Length
    1 weeks per course
  • Effort
    1-2 hours per week, per course
  • Number of Courses
    7 courses in program
  • Price (USD)
    $339 $308 for entire program You save $31 USD

Courses in the Professional Program

This course will review the clinical trial data on the efficacy and safety of non-vitamin K oral anticoagulants (NOACs) for prevention of stroke in patients with atrial fibrillation (AF).
Starts on November 20, 2018
A case-based review of the newer agents available for the treatment of patients with diabetes focusing on the practical application of these agents for clinicians in practice and when to best consider their use in clinical care.
Starts on November 20, 2018
This course will provide an overview of recurrent clostridium difficile infections, including mechanism of disease and treatment options.
Starts on November 20, 2018
This course will review the appropriate use and limitations of procalcitonin testing in the diagnosis and antibiotic management of infectious diseases.
Starts on December 13, 2018
This course provides an update and clinical case discussions on new pharmacologic treatments for heart failure, including angiotensin-neprilysin inhibitors, ivabradine, and iron.
Starts on December 13, 2018
A review of pre-exposure prophylaxis (PrEP) to prevent the transmission of HIV including an overview of the risks and benefits of PrEP, appropriate patient selection, counseling, and monitoring.
Starts on January 3, 2019
This course focuses on an update in cancer immunotherapy.
Starts on January 3, 2019

Instructors

Christian T. Ruff, MD, MPH
Assistant Professor of Medicine, Harvard Medical School; Director of General Cardiology, Cardiovascular Division, Brigham and Women’s Hospital; Investigator, TIMI Study Group
Florencia Halperin, MD
Instructor in Medicine, Harvard Medical School; Chief of Endocrinology and Brigham and Women's Faulkner Hospital; Co-Director, Program for Weight Management, Brigham and Women’s Hospital
Dr. Jessica Allegretti, MD
Assistant Professor of Medicine, Harvard Medical School; Director of Clinical Trials, Crohn’s and Colitis Center, Brigham and Women’s Hospital
Chanu Rhee, MD, MPH
Assistant Professor of Population Medicine and Medicine, Harvard Medical School; Physician, Critical Care and Infectious Disease, Brigham and Women’s Hospital
Anju Nohria, MD
Assistant Professor of Medicine, Harvard Medical School; Director, Cardio-Oncology Program, Brigham and Women's Hospital/Dana Farber Cancer Institute
Kevin Ard, MD, MPH
Instructor in Medicine at Harvard Medical School; Director, Sexually Transmitted Infection Clinic, Massachusetts General Hospital; Medical Director, National LGBT Health Education Center, Fenway Institute
Stephen Hodi, MD
Professor of Medicine, Harvard Medical School; Director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center